关注
Daniele Altomare
Daniele Altomare
Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Italy
在 unibs.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Brain atrophy in Alzheimer’s disease and aging
L Pini, M Pievani, M Bocchetta, D Altomare, P Bosco, E Cavedo, ...
Ageing research reviews 30, 25-48, 2016
7572016
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
GB Frisoni, D Altomare, DR Thal, F Ribaldi, R van der Kant, ...
Nature Reviews Neuroscience 23 (1), 53-66, 2022
2992022
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
1212022
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission …
F Nobili, J Arbizu, F Bouwman, A Drzezga, F Agosta, P Nestor, Z Walker, ...
European Journal of Neurology 25 (10), 1201-1217, 2018
1082018
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
Z Walker, F Gandolfo, S Orini, V Garibotto, F Agosta, J Arbizu, F Bouwman, ...
European journal of nuclear medicine and molecular imaging 45, 1534-1545, 2018
1072018
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F …
M Boccardi, D Altomare, C Ferrari, C Festari, UP Guerra, B Paghera, ...
JAMA neurology 73 (12), 1417-1424, 2016
952016
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia
PJ Nestor, D Altomare, C Festari, A Drzezga, J Rivolta, Z Walker, ...
European journal of nuclear medicine and molecular imaging 45, 1509-1525, 2018
942018
Clinical utility of FDG-PET for the clinical diagnosis in MCI
J Arbizu, C Festari, D Altomare, Z Walker, F Bouwman, J Rivolta, S Orini, ...
European journal of nuclear medicine and molecular imaging 45, 1497-1508, 2018
752018
Applying the ATN scheme in a memory clinic population: The ABIDE project
D Altomare, A de Wilde, R Ossenkoppele, W Pelkmans, F Bouwman, ...
Neurology 93 (17), e1635-e1646, 2019
712019
Multitracer model for staging cortical amyloid deposition using PET imaging
LE Collij, F Heeman, G Salvadó, S Ingala, D Altomare, A de Wilde, ...
Neurology 95 (11), e1538-e1553, 2020
672020
Diagnosis of mild cognitive impairment due to Alzheimer’s disease with transcranial magnetic stimulation
A Padovani, A Benussi, V Cantoni, V Dell’Era, MS Cotelli, S Caratozzolo, ...
Journal of Alzheimer's Disease 65 (1), 221-230, 2018
612018
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
GB Frisoni, D Altomare, F Ribaldi, N Villain, C Brayne, N Mukadam, ...
The Lancet Regional Health–Europe 26, 2023
582023
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies
GB Frisoni, JL Molinuevo, D Altomare, E Carrera, F Barkhof, J Berkhof, ...
Alzheimer's & Dementia 16 (10), 1457-1468, 2020
562020
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6
JM Ranson, T Rittman, S Hayat, C Brayne, F Jessen, K Blennow, ...
Alzheimer's Research & Therapy 13, 1-12, 2021
532021
AMYPAD diagnostic and patient management study: rationale and design
GB Frisoni, F Barkhof, D Altomare, J Berkhof, M Boccardi, E Canzoneri, ...
Alzheimer's & Dementia 15 (3), 388-399, 2019
412019
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6
D Altomare, JL Molinuevo, C Ritchie, F Ribaldi, E Carrera, B Dubois, ...
Alzheimer's research & therapy 13, 1-11, 2021
402021
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders
F Nobili, C Festari, D Altomare, F Agosta, S Orini, K Van Laere, J Arbizu, ...
European journal of nuclear medicine and molecular imaging 45, 1557-1566, 2018
392018
Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services—part 4 of 6
A Solomon, R Stephen, D Altomare, E Carrera, GB Frisoni, J Kulmala, ...
Alzheimer's research & therapy 13, 1-15, 2021
382021
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
I Lopes Alves, LE Collij, D Altomare, GB Frisoni, L Saint‐Aubert, P Payoux, ...
Alzheimer's & Dementia 16 (5), 750-758, 2020
382020
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
A Drzezga, D Altomare, C Festari, J Arbizu, S Orini, K Herholz, P Nestor, ...
European journal of nuclear medicine and molecular imaging 45, 1487-1496, 2018
362018
系统目前无法执行此操作,请稍后再试。
文章 1–20